Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
BillionToOne, Inc.

BillionToOne, Inc. (BLLN) Stock Overview

Explore BillionToOne, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BLLN●NASDAQ
HealthcareMedical - Diagnostics & Research
$149.97
$7.72(5.43%)
U.S. Market opens in 12h 46m

BillionToOne, Inc. (BLLN)

Meyka AI Score

Z

Key Financials

Market Cap6.9B
P/E Ratio290.63
EPS (TTM)$0.55
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$122.26
3 Months$138.37
1 Year Target$109.98

BLLN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BillionToOne, Inc. (NASDAQ: BLLN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, BillionToOne, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BLLN on the NASDAQ shows an RSI of 72.06, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $109.98 for the NASDAQ listing.

Key metrics behind BillionToOne, Inc.'s NASDAQ-traded stock include a P/E ratio of 290.63 and a market capitalization of 6.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BLLN on the NASDAQ.

Price Performance (NASDAQ: BLLN)

1-Day Change
5.43%
5-Day Change
6.96%
1-Month Change
21.53%
3-Month Change
87.70%
6-Month Change
76.12%
Year-to-Date (YTD) Change
83.25%
1-Year Change
37.66%
3-Year Change
37.66%
5-Year Change
37.66%
All-Time (Max) Change
37.66%

Contact Information

https://www.billiontoone.com
(650) 460-2551
1035 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

7,130 Employees
IPO DateNov 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions